CAJ | 학술논문

我国食管癌的临床诊治一直以来以参照西方国家的经验或依据自己的经验来实施,没有形成一套适合我国国情的规范化诊治标准.由于缺乏相互交流学习的机会,我国整体规范化诊治水平低、先进技术应用少和各地诊治方案各不相同,食管癌的治疗效果一直不理想,术后总体5年生存率长期徘徊在30％～40％.本文总结了自本世纪初逐步开展的系列食管癌巡讲学术推广活动及食管癌规范化诊治指南的编写与解读历程,并对其在食管癌诊治领域所产生的影响进行评述.
아국식관암적림상진치일직이래이삼조서방국가적경험혹의거자기적경험래실시,몰유형성일투괄합아국국정적규범화진치표준.유우결핍상호교류학습적궤회,아국정체규범화진치수평저、선진기술응용소화각지진치방안각불상동,식관암적치료효과일직불이상,술후총체5년생존솔장기배회재30％～40％.본문총결료자본세기초축보개전적계렬식관암순강학술추엄활동급식관암규범화진치지남적편사여해독역정,병대기재식관암진치영역소산생적영향진행평술.
For a long time,the diagnosis and treatment protocol for esophageal cancer has been made either entirely based on the experience of Western countries or on our own experience alone.A suitable standardized guideline for diagnosis and treatment of esophageal cancer in our country has not been estaldished until 2010.Due to lack of opportunities for mutual exchange and learning,the overall level of standardized diagnosis and treatment was relatively low in China.In addition,less advanced technologies were applied and varying treatment protocols were implemented in different districts,the treatment results has been unsatisfactory,and the overall 5-year survival rate after surgical treatment has been maintained from 30％ to 40％.Therefore,it is imperative that China needs to conduct its own clinical studies and establish its own suitable standardized treatment and diagnosis guideline for esophageal cancer.This article reviews and also made comments on the process of academic speaking tour and development of standardized diagnosis and treatment guidelines as well as the problems resolved by these activities for esophageal cancer since the beginning of this century.